TNF-related apoptosis-inducing ligand-expressing mesenchymal stem cell therapy (Temple Therapeutics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTNF-related apoptosis-inducing ligand-expressing mesenchymal stem cell therapy (Temple Therapeutics)
Drug Alias NameTRAIL-expressing MSC therapy (Temple Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cells stimulantsApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTemple Therapeutics Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTemple Therapeutics Bv
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A